Cargando…
Anthracyclines inhibit SARS-CoV-2 infection
Vaccines and drugs are two effective medical interventions to mitigate SARS-CoV-2 infection. Three SARS-CoV-2 inhibitors, remdesivir, paxlovid, and molnupiravir, have been approved for treating COVID-19 patients, but more are needed, because each drug has its limitation of usage and SARS-CoV-2 const...
Autores principales: | Wang, Zhen, Pan, Qinghua, Ma, Ling, Zhao, Jianyuan, McIntosh, Fiona, Liu, Zhenlong, Ding, Shilei, Lin, Rongtuan, Cen, Shan, Finzi, Andrés, Liang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305762/ https://www.ncbi.nlm.nih.gov/pubmed/37379907 http://dx.doi.org/10.1016/j.virusres.2023.199164 |
Ejemplares similares
-
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase
por: Zhao, Jianyuan, et al.
Publicado: (2021) -
The interferon-induced MxB protein inhibits an early step of HIV-1 infection
por: Liu, Zhenlong, et al.
Publicado: (2013) -
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors
por: Zhao, Jianyuan, et al.
Publicado: (2021) -
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
por: Zhao, Jianyuan, et al.
Publicado: (2022) -
SARS-Cov-2 variants of concern decelerate the dynamics of spike open conformation as an evolutionary strategy
por: Yang, Ziwei, et al.
Publicado: (2022)